apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma (2018) Scheich S, Ahrens M, Goekbuget N, Boleti E, Burkholder , Escudier BJ, Goebell P, et al. Conference contribution SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer (2018) Schmidkonz C, Cordes M, Beck M, Goetz TI, Schmidt D, Prante O, Bäuerle T, et al. Journal article 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer (2018) Schmidkonz C, Cordes M, Schmidt D, Bäuerle T, Goetz TI, Beck M, Prante O, et al. Journal article 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer (2018) Schmidkonz C, Hollweg C, Beck M, Reinfelder J, Götz T, Sanders JC, Schmidt D, et al. Journal article Metastatic prostate cancer. Update: position paper for the use of chemotherapy (2017) Ohlmann CH, Goebell P, Grimm MO, Klier J, Koenig F, Machtens S, Schostak M, et al. Journal article Prognostic factors for overall survival of patients with advanced renal cell carcinoma - data from the German prospective RCC-Registry (2017) Goebell P, Mueller L, Staehler M, Mueller M, Frank M, Kruggel L, Jaenicke M, Marschner N Conference contribution Real world effectiveness and safety of pazopanib and everolimus in metastatic renal cell carcinoma: first interim analysis of the PAZOREAL study (2017) Bedke J, Welslau M, Boegemann M, Schostak M, Hering-Schubert C, Petzoldt A, Wolf T, et al. Conference contribution RECREATE - A retrospective chart review to assess the treatment reality for mRCC patients following 1st line Pazopanib: reflecting a changing mRCC treatment landscape (2017) Hegele A, Van Der Heyde E, Goebell P, Zengerling F, Hbner A, Klier J, Belz H, et al. Conference contribution Prognostic factors for overall survival of patients with advanced renal cell carcinoma - data from the German prospective RCC-Registry (2017) Goebell P, Mueller L, Staehler M, Mueller M, Frank M, Kruggel L, Jaenicke M, Marschner N Conference contribution The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape (2017) Goebell P, Doehn C, Gruellich C, Gruenwald V, Steiner T, Ehness R, Welslau M Journal article